Finance entity

European Life Sciences Coalition

organization

Every one of those 1 sits in a single category, markets. Of the tracked stories, 1 of 1 also mention Cushman & Wakefield, the most common co-covered peer. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window.

Last mentioned: Feb 18, 2026

Entity pulse

Recent coverage · European Life Sciences Coalition

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about European Life Sciences Coalition

Every one of those 1 sits in a single category, markets. Of the tracked stories, 1 of 1 also mention Cushman & Wakefield, the most common co-covered peer. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window. Their average consequence score of 7 runs above the beat's 6.7 for that window. We currently track 1 Finance story that mention European Life Sciences Coalition, all published on February 18, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 90 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering European Life Sciences Coalition. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning European Life Sciences Coalition 1

Markets Bearish

European VCs Form Coalition to Bridge Life Sciences Funding Gap

Leading European venture capital firms have launched the European Life Sciences Coalition to address a systemic funding crisis and prevent the migration of high-growth biotech firms to U.S. markets. The initiative seeks to unlock institutional capital and harmonize regulations to bridge the late-stage investment gap between Europe and North America.

3 sources

Source: BioXconomy · Cushman & Wakefield

European Life Sciences Coalition is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.